IP Verse

Arbutus Biopharma vs. Moderna - UPC_CFI_192/2025

The case UPC_CFI_192/2025 was filed by the plaintiff Arbutus Biopharma, Genevant Sciences against the defendant Moderna on 03 Mar, 2025.

Case Timeline

03 Mar, 2025
Case Filed
08 Jul, 2025
Counterclaim for Revocation
08 Jul, 2025
Interim Conference
Today Nov 1, 2025
Oral Procedure
Decision

Case Details

    Case Number:

    UPC_CFI_192/2025

    Patent Number:

    EP4241767

    Filing Date:

    03 Mar, 2025

    Proceeding Type:

    Infringement

    Case Phase:

    Written Phase

    Plaintiffs:

    • Arbutus Biopharma
    • Genevant Sciences

    Plaintiff Representative:

    • Mark VAN GARDINGEN

    Defendants:

    • Moderna

    Defendant Representative:

    • Kilian Seidel

    Judges:

    • Edger Brinkman
    • Margot Kokke
    • Samuel Granata
    • Xavier Dorland-Galliot

    Court Division:

    First Instance, Local Division - The Hague

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend
Sep 10, 2025Exhibit A118 Moderna Italy Webpage
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)
Sep 10, 2025Acknowledgement Of Lodging
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend
Aug 18, 2025Panel Appointment
Aug 18, 2025Outcome Of The Order
Aug 18, 2025Headnote And Keywords
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop
Aug 6, 2025R.37
Aug 6, 2025R
Aug 6, 2025Hearing Dates
Aug 4, 2025Opportunity To Comment
Jul 28, 2025Reference To Response Of Genevant
Jul 25, 2025Receipt
Jul 25, 2025Acknowledgement Of Lodging
Jul 23, 2025Reference To Response Of Genevant
Jul 23, 2025R.262.2 Application
Jul 23, 2025Exhibit A090 Confidential
Jul 23, 2025Exhibit A089
Jul 23, 2025Exhibit A088
Jul 23, 2025Confidential Reply Security For Costs
Jul 17, 2025Exhibit Fbd 05
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025
Jul 10, 2025Formal Checks Notification Of Positive Outcome
Jul 9, 2025Template Order
Jul 9, 2025Receipt
Jul 9, 2025Opportunity To Comment
Jul 9, 2025Exhibit Fbd 12
Jul 9, 2025Exhibit Fbd 11
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)
Jul 8, 2025Exhibit Fbd T 9
Jul 8, 2025Exhibit Fbd T 8
Jul 8, 2025Exhibit Fbd T 70
Jul 8, 2025Exhibit Fbd T 7
Jul 8, 2025Exhibit Fbd T 69
Jul 8, 2025Exhibit Fbd T 68
Jul 8, 2025Exhibit Fbd T 67
Jul 8, 2025Exhibit Fbd T 66
Jul 8, 2025Exhibit Fbd T 65
Jul 8, 2025Exhibit Fbd T 64
Jul 8, 2025Exhibit Fbd T 63
Jul 8, 2025Exhibit Fbd T 62
Jul 8, 2025Exhibit Fbd T 61
Jul 8, 2025Exhibit Fbd T 60
Jul 8, 2025Exhibit Fbd T 6
Jul 8, 2025Exhibit Fbd T 59
Jul 8, 2025Exhibit Fbd T 58
Jul 8, 2025Exhibit Fbd T 57
Jul 8, 2025Exhibit Fbd T 56
Jul 8, 2025Exhibit Fbd T 55
Jul 8, 2025Exhibit Fbd T 54
Jul 8, 2025Exhibit Fbd T 53
Jul 8, 2025Exhibit Fbd T 52
Jul 8, 2025Exhibit Fbd T 51
Jul 8, 2025Exhibit Fbd T 50
Jul 8, 2025Exhibit Fbd T 5
Jul 8, 2025Exhibit Fbd T 49
Jul 8, 2025Exhibit Fbd T 48
Jul 8, 2025Exhibit Fbd T 47
Jul 8, 2025Exhibit Fbd T 46
Jul 8, 2025Exhibit Fbd T 45
Jul 8, 2025Exhibit Fbd T 44
Jul 8, 2025Exhibit Fbd T 43
Jul 8, 2025Exhibit Fbd T 42
Jul 8, 2025Exhibit Fbd T 41
Jul 8, 2025Exhibit Fbd T 40
Jul 8, 2025Exhibit Fbd T 4
Jul 8, 2025Exhibit Fbd T 39
Jul 8, 2025Exhibit Fbd T 38
Jul 8, 2025Exhibit Fbd T 37
Jul 8, 2025Exhibit Fbd T 36
Jul 8, 2025Exhibit Fbd T 35
Jul 8, 2025Exhibit Fbd T 34
Jul 8, 2025Exhibit Fbd T 33
Jul 8, 2025Exhibit Fbd T 32
Jul 8, 2025Exhibit Fbd T 31
Jul 8, 2025Exhibit Fbd T 30
Jul 8, 2025Exhibit Fbd T 3
Jul 8, 2025Exhibit Fbd T 29
Jul 8, 2025Exhibit Fbd T 28
Jul 8, 2025Exhibit Fbd T 27
Jul 8, 2025Exhibit Fbd T 26
Jul 8, 2025Exhibit Fbd T 25
Jul 8, 2025Exhibit Fbd T 24
Jul 8, 2025Exhibit Fbd T 23
Jul 8, 2025Exhibit Fbd T 22
Jul 8, 2025Exhibit Fbd T 21
Jul 8, 2025Exhibit Fbd T 20
Jul 8, 2025Exhibit Fbd T 2
Jul 8, 2025Exhibit Fbd T 19
Jul 8, 2025Exhibit Fbd T 18
Jul 8, 2025Exhibit Fbd T 17
Jul 8, 2025Exhibit Fbd T 16
Jul 8, 2025Exhibit Fbd T 15
Jul 8, 2025Exhibit Fbd T 14
Jul 8, 2025Exhibit Fbd T 13
Jul 8, 2025Exhibit Fbd T 12
Jul 8, 2025Exhibit Fbd T 11
Jul 8, 2025Exhibit Fbd T 10
Jul 8, 2025Exhibit Fbd T 1
Jul 8, 2025Exhibit Fbd 9
Jul 8, 2025Exhibit Fbd 8
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5
Jul 8, 2025Exhibit Fbd 6
Jul 8, 2025Exhibit Fbd 5
Jul 8, 2025Exhibit Fbd 4
Jul 8, 2025Exhibit Fbd 3
Jul 8, 2025Exhibit Fbd 12
Jul 8, 2025Exhibit Fbd 11
Jul 8, 2025Exhibit Fbd 10
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence
Jul 8, 2025Acknowledgement Of Lodging
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order
Jun 2, 2025Response To Request For Rectification
May 28, 2025Opportunity To Comment
May 27, 2025Receipt
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome
May 8, 2025Exhibit A087 Notice European Tender
May 8, 2025Comment On Preliminary Objection
May 8, 2025Comment On Preliminary Objection
May 7, 2025Exhibit A087 Notice European Tender
May 7, 2025Comment On Preliminary Objection
May 7, 2025Comment On Preliminary Objection
May 6, 2025Notification Of Service
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As
May 5, 2025Acknowledgement Of Access To Case
May 1, 2025Notification Of Service
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh
Apr 25, 2025Preliminary Objection
Apr 25, 2025Notification Of Service
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.
Apr 24, 2025Preliminary Objections Of Defendants 1 14
Apr 24, 2025Exhibit Fbd 2
Apr 24, 2025Acknowledgement Of Access To Case
Apr 23, 2025Preliminary Objection
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk
Apr 22, 2025Notification Of Service
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc
Apr 17, 2025Outcome Of The Order
Apr 17, 2025Headnote And Keywords
Apr 17, 2025Further Response Re Deadline Extension
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc
Apr 15, 2025Response Re Request For Deadline Extension
Apr 15, 2025Receipt
Apr 14, 2025Receipt
Apr 14, 2025R 9 Aplication Reply To R 9 Request
Apr 10, 2025Template Order
Apr 10, 2025Opportunity To Comment
Apr 9, 2025Request For Deadline Extension
Apr 9, 2025Receipt
Apr 9, 2025Opportunity To Comment
Apr 9, 2025Exhibit Fbd 1
Apr 8, 2025Notification Of Service
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.
Apr 8, 2025Acknowledgement Of Access To Case
Mar 31, 2025Acknowledgement Of Access To Case
Mar 28, 2025Acknowledgement Of Access To Case
Mar 24, 2025Acknowledgement Of Access To Case
Mar 17, 2025Panel Appointment
Mar 17, 2025Communicationcheck
Mar 13, 2025Letter For Service
Mar 11, 2025Document From Epo
Mar 11, 2025Communicationcheck
Mar 6, 2025Receipt
Mar 6, 2025Panel Appointment
Mar 6, 2025Formal Checks Notification Of Positive Outcome
Mar 6, 2025Epo Request For Case Pending
Mar 5, 2025Statement Of Claim EP767 Signed
Mar 5, 2025Statement Of Claim EP767Da
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release
Mar 5, 2025Exhibit A079 Lonza Press Release
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register
Mar 5, 2025Exhibit A069 Moderna France Trade Register
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid
Mar 5, 2025Exhibit A063 Moderna Es Trade Register
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser
Mar 5, 2025Exhibit A052 Moderna Press Release Tender
Mar 5, 2025Exhibit A051 Ec Press Release Tender
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register
Mar 5, 2025Exhibit A047 Modernacovid19Global Website
Mar 5, 2025Exhibit A046 Modernatx Website
Mar 5, 2025Exhibit A045 Domain Registrations Moderna
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt
Mar 5, 2025Exhibit A043 Moderna Inc Press Release
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August
Mar 5, 2025Exhibit A035 Mresvia Smpc
Mar 5, 2025Exhibit A034 EP4241767A2
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April
Mar 5, 2025Exhibit A029 D2 US6320017B1
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November
Mar 5, 2025Exhibit A014 Samaridou
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein
Mar 5, 2025Exhibit A012 CR OSS Cen News
Mar 5, 2025Exhibit A011 Regalado Mit Technology
Mar 5, 2025Exhibit A010 Corbett Nature Review
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement
Mar 5, 2025Exhibit A007 Zimmerman
Mar 5, 2025Exhibit A006 Spikevax Smpc
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02
Mar 5, 2025Exhibit A003 EP4241767B1
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus
Mar 5, 2025Exhibit A001 National Register Excerpts
Mar 4, 2025Formal Checks Request For Correction
Mar 3, 2025Statement Of Claim EP767 Signed
Mar 3, 2025Soc EP767Da
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release
Mar 3, 2025Exhibit A079 Lonza Press Release
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register
Mar 3, 2025Exhibit A069 Moderna France Trade Register
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid
Mar 3, 2025Exhibit A063 Moderna Es Trade Register
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser
Mar 3, 2025Exhibit A052 Moderna Press Release Tender
Mar 3, 2025Exhibit A051 Ec Press Release Tender
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register
Mar 3, 2025Exhibit A047 Modernacovid19Global Website
Mar 3, 2025Exhibit A046 Modernatx Website
Mar 3, 2025Exhibit A045 Domain Registrations Moderna
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt
Mar 3, 2025Exhibit A043 Moderna Inc Press Release
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August
Mar 3, 2025Exhibit A034 EP4241767A2
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April
Mar 3, 2025Exhibit A029 D2 US6320017B1
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November
Mar 3, 2025Exhibit A014 Samaridou
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein
Mar 3, 2025Exhibit A012 CR OSS Cen News
Mar 3, 2025Exhibit A011 Regalado Mit Technology
Mar 3, 2025Exhibit A010 Corbett Nature Review
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement
Mar 3, 2025Exhibit A007 Zimmerman
Mar 3, 2025Exhibit A006 Spikevax Smpc
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02
Mar 3, 2025Exhibit A003 EP4241767B1
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus
Mar 3, 2025Exhibit A001 National Register Excerpts
Mar 3, 2025Acknowledgement Of Lodging

More cases involving EP4241767B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
CC_31831/2025Jul 8, 2025ModernaArbutus Biopharma
UPC_CFI_607/2025Jul 8, 2025ModernaArbutus Biopharma
ACT_10284/2025Mar 3, 2025Arbutus Biopharma, Genevant SciencesModerna

More cases involving Arbutus Biopharma

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus BiopharmaModerna
ORD_34391/2025Aug 6, 2025Arbutus BiopharmaModerna
APP_34202/2025Aug 1, 2025Arbutus Biopharma -

More cases involving Moderna

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
ORD_34391/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
APP_33094/2025Jul 17, 2025Moderna -